Non-invasive Prenatal Testing Market is expected to reach USD 9.06 Billion by 2029 and is expected to undergo a CAGR of 13.80%
Non-invasive Prenatal Testing Market Size And Forecast by 2031
Data Bridge Market Research analyses that the Global Non-invasive Prenatal Testing Market which was USD 3.22 Million in 2021 is expected to reach USD 9.06 Billion by 2029 and is expected to undergo a CAGR of 13.80% during the forecast period of 2021 to 2029. Non-invasive Prenatal Testing Market report provides a holistic evaluation of the market. The report offers comprehensive analysis of Size, Share, Scope, Demand, Growth, Value, Opportunities, Industry Statistics, Industry Trends, Industry Share, Revenue Analysis, Revenue Forecast, Future Scope, Challenges, Growth Drivers, leaders, graph, insights, Research Report, companies, overview, outlook and factors that are playing a substantial role in the market.
Global Non-invasive Prenatal Testing Market Segmentation Analysis
Global Non-invasive Prenatal Testing Market, By Product and Services (Products, Services), Method (Ultrasound Detection, Biochemical Screening Test, Cell-Free DNA in Maternal Plasma Tests), Application (Trisomy, Microdeletion Syndrome, Other), End-User (Diagnostic Laboratories, Hospitals), Test Type (Materni21, Harmony, Panorama, Verify, NIFTY, Others), Technology (NGS, WGS, Others) — Industry Trends and Forecast to 2029
Get a Sample PDF of Report — https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-non-invasive-prenatal-testing-market
Which are the top companies operating in the Non-invasive Prenatal Testing Market?
The “Global Non-invasive Prenatal Testing Market ”study report will provide a valuable insight with an emphasis on the global market. The report profiles noticeable organizations working in the water purifier showcase and the triumphant methodologies received by them. It likewise reveals insights about the share held by each organization and their contribution to the Non-invasive Prenatal Testing Market extension. This Non-invasive Prenatal Testing Market report provides the information of the Top 10 Companies in Non-invasive Prenatal Testing Market in the market their business strategy, financial situation etc.
**Segments**
- **By Product**: In 2021, the non-invasive prenatal testing market was dominated by the consumables segment due to the high demand for assay kits and reagents. However, by 2029, the services segment is expected to witness significant growth with the increasing popularity of NIPT services among pregnant women.
- **By Method**: Sequential method held the largest market share in 2021, owing to its high accuracy and reliability. Nonetheless, the semi-direct method is projected to experience the fastest growth by 2029, driven by advancements in technology and research.
- **By Application**: In 2021, the screening segment accounted for the largest share in the non-invasive prenatal testing market. By 2029, diagnostic applications are anticipated to gain traction due to the growing need for early detection of genetic abnormalities.
- **By End-User**: Hospitals and clinics were the leading end-users of non-invasive prenatal testing in 2021. However, the diagnostic laboratories segment is forecasted to exhibit substantial growth by 2029 as more laboratories adopt NIPT technology.
**Market Players**
- Illumina, Inc.
- F. Hoffmann-La Roche Ltd.
- Natera, Inc.
- PerkinElmer Inc.
- GE Healthcare
- Agilent Technologies, Inc.
- Pacific Biosciences of California, Inc.
- Thermo Fisher Scientific Inc.
- Beijing Genomic Institute (BGI)
- Laboratory Corporation of America Holdings
The global non-invasive prenatal testing market is poised for significant growth between 2021 and 2029 due to the increasing awareness about prenatal testing and rising adoption of advanced technologies in healthcare. Companies such as Illumina, Inc., F. Hoffmann-La Roche Ltd., and Natera, Inc. are at the forefront of driving innovation and expanding their market presence. The market is witnessing a shift towards services, with a focus on enhancing the accuracy and efficiency of NIPT. As technology continuesThe non-invasive prenatal testing market is experiencing significant growth and evolution driven by various factors such as increasing awareness about prenatal testing and the adoption of advanced technologies in the healthcare sector. This market is segmented based on product, method, application, and end-user, each playing a crucial role in shaping the industry landscape. In terms of products, consumables were dominant in 2021, primarily due to the high demand for assay kits and reagents. However, services are expected to witness substantial growth by 2029 as NIPT services become more popular among pregnant women seeking accurate and reliable testing options. This shift towards services highlights a changing market dynamic where the focus is shifting towards improving the overall testing experience and accuracy.
When looking at the method segment, sequential method held the largest market share in 2021 due to its recognized accuracy and reliability. Nevertheless, the semi-direct method is projected to grow significantly by 2029, fueled by advancements in technology and ongoing research efforts aimed at enhancing testing methodologies. This shift towards the semi-direct method underscores the importance of continuously improving testing techniques to meet the evolving needs of healthcare providers and patients seeking NIPT services.
In terms of applications, the screening segment dominated the market in 2021, reflecting the emphasis on identifying potential risks and abnormalities during pregnancy. However, by 2029, diagnostic applications are expected to gain traction as the need for early detection of genetic abnormalities becomes increasingly important. This trend highlights a growing awareness of the importance of early intervention and personalized treatment plans facilitated by accurate diagnostic testing through NIPT.
Regarding end-users, hospitals and clinics were the primary users of non-invasive prenatal testing in 2021. However, diagnostic laboratories are projected to exhibit substantial growth by 2029, driven by the increasing adoption of NIPT technology and the integration of testing services into laboratory workflows. This shift towards diagnostic laboratories as key end-users underscores the importance of efficient testing processes and infrastructure to meet the growing demand for prenatal testing services.
Overall, the global non-invasive**Market Players:**
- Illumina, Inc. (U.S)
- Thermo Fisher Scientific Inc. (U.S)
- General Electric (U.S)
- BGI Group (China)
- Agilent Technologies, Inc. (U.S)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- PerkinElmer Inc. (U.S)
- Laboratory Corporation of America Holdings (U.S)
- Natera, Inc. (U.S)
- Yourgene Health (U.S)
- Eurofins LifeCodexx GmbH (Germany)
- Quest Diagnostics Incorporated (U.S)
- Myriad Genetics Inc. (U.S)
- NIPD Genetics (Cyprus)
- Next Biosciences (South Africa)
The non-invasive prenatal testing market is experiencing a significant evolution driven by factors such as increasing awareness of prenatal testing and the adoption of advanced healthcare technologies. This market is segmented by product, method, application, and end-user, all of which play pivotal roles in shaping the industry landscape. Consumables dominated the market in 2021 due to the high demand for assay kits and reagents, but services are expected to grow significantly by 2029 as pregnant women seek accurate and reliable NIPT services. This shift towards services indicates a market dynamic focused on improving testing accuracy and efficiency.
The sequential method held the largest market share in 2021 for its recognized accuracy, but the semi-direct method is projected to grow significantly by 202
Explore Further Details about This Research Non-invasive Prenatal Testing Market Report https://www.databridgemarketresearch.com/reports/global-non-invasive-prenatal-testing-market
Research Methodology of Data bridge Market Research:
Data Bridge Market Research typically follows a comprehensive research methodology for analyzing and reporting on market trends, including the Non-invasive Prenatal Testing Market. The research methodology generally involves the following steps:
1. Data Collection
- Primary Research: This involves conducting interviews, surveys, and direct interactions with industry experts, market participants, and key opinion leaders. Primary data is crucial for gaining insights into the market’s current dynamics, trends, and growth factors.
- Secondary Research: This includes gathering data from publicly available sources like company reports, press releases, industry journals, government publications, and reputable databases. Secondary research helps in understanding the market’s historical trends and the competitive landscape.
2. Market Segmentation and Data Analysis
- Segmentation: The Non-invasive Prenatal Testing Market is segmented based on various factors such as type, application, region, and end-user. This segmentation allows for a more detailed analysis of each Non-invasive Prenatal Testing Market segment.
- Data Analysis: Advanced analytical tools and techniques, such as SWOT analysis, PESTLE analysis, Porter’s Five Forces analysis, and regression analysis, are used to interpret the data. These tools help in identifying key market trends, growth drivers, opportunities, and challenges.
3. Market Estimation
- Top-Down and Bottom-Up Approaches: These approaches are used to estimate and validate the market size. The top-down approach involves analyzing the overall market and then narrowing it down to specific segments, while the bottom-up approach starts from individual segments and aggregates them to estimate the total market size.
- Data Triangulation: Multiple data sources are compared and analyzed to ensure the accuracy and reliability of the market estimates.
4. Validation
- Expert Validation: The findings and market estimates are validated through discussions with industry experts and key stakeholders. This step ensures that the data and insights are accurate and reflect the market reality.
- Cross-Verification: The data is cross-verified with multiple sources to ensure consistency and accuracy.
5. Report Compilation and Presentation
- Drafting the Report: Once the data analysis is complete, the findings are compiled into a comprehensive report. The report includes a detailed analysis of market trends, forecasts, competitive landscape, and strategic recommendations.
- Final Review: The report undergoes a final review to ensure that it meets the quality standards and provides valuable insights to the clients.
6. Ongoing Updates
https://medium.com/@brendacunninghame911/business-process-as-a-service-bpaas-market-9f897269a58e
https://medium.com/@rachelhudsone/craft-soda-market-is-expected-to-reach-usd-1054-51-03618ae6858f
https://medium.com/@rachelhudsone/process-analytics-service-market-7e21a0f40668
https://medium.com/@jeetkushwaha9361/fresh-food-market-is-expected-to-reach-usd-4871-4-3a7e7c46a349
https://medium.com/@amalkumar1839/tissue-towel-market-05c5dfb84065
https://medium.com/@amalkumar1839/beverage-dispenser-equipment-market-dd0f7ca0110d
https://medium.com/@amalkumar1839/onion-powder-market-4187563b0a99
https://medium.com/@ranjaymitra5/facial-recognition-market-will-exhibit-a-cagr-of-16-10-c490f830731b
Data Bridge Market Research:
Today’s trends are a great way to predict future events!
Data Bridge Market Research is a market research and consulting firm known for its innovative and unique approach, coupled with unparalleled resilience and integrated methods. We are committed to identifying prime market opportunities and delivering insightful information to help your business excel in the marketplace. Data Bridge provides customized solutions to complex business challenges, ensuring a seamless decision-making process. Founded in Pune in 2015, Data Bridge is the result of profound wisdom and extensive experience.
Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC: +653 1251 975
Comments
Post a Comment